CEL-SCI Files S-1 for Security Registration

Ticker: CVM · Form: S-1 · Filed: Apr 17, 2026 · CIK: 0000725363

Sentiment: neutral

Topics: registration, securities, s-1

TL;DR

CEL-SCI just filed an S-1, looks like they're raising capital. Keep an eye on this one.

AI Summary

CEL-SCI Corporation filed an S-1 form on April 17, 2026, to register securities. The filing includes exhibits such as a placement agent agreement, legal opinions, and consents from BDO USA PC and HART HART LLC. The company, operating in the biological products sector, is located at 8229 Boone Blvd., Suite 802, Vienna, VA 22182.

Why It Matters

This S-1 filing indicates CEL-SCI Corporation is preparing to offer new securities, which could impact its capital structure and future operations.

Risk Assessment

Risk Level: medium — S-1 filings often precede significant corporate actions like stock offerings, which carry inherent risks for investors.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of this S-1 filing?

The S-1 filing is a general form for the registration of securities under the Securities Act of 1933, indicating CEL SCI CORP's intent to offer securities.

When was this S-1 filing accepted by the SEC?

The S-1 filing was accepted on 2026-04-17 at 17:07:27.

What are some of the key exhibits included with this filing?

Key exhibits include a PLACEMENT AGENT AGREEMENT (cvm_ex1.htm), LEGAL OPINION (cvm_ex5.htm), and CONSENT OF BDO USA PC (cvm_ex231.htm) and CONSENT OF HART HART LLC (cvm_ex232.htm).

What is CEL SCI CORP's business address?

CEL SCI CORP's business address is 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182.

What industry does CEL SCI CORP operate in?

CEL SCI CORP operates in the Biological Products, (No Diagnostic Substances) sector, as indicated by its SIC code 2836.

Filing Details

This Form S-1 (Form S-1) was filed with the SEC on April 17, 2026 regarding CEL SCI CORP (CVM).

View full filing on EDGAR

View Full Filing

View this S-1 filing on SEC EDGAR

View on Read The Filing